Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01831752 · ClinicalTrials.gov registry record
Performance Evaluation of a Non-Invasive Glucose Monitor as Compared to CGM Data Acquired by the iPro2
A clinical trial, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- 9
- Enrollment target
NCT01831752 is a clinical trial that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 9 participants.
The verdict
NCT01831752 has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This study is for adults and adolescents with type 1 diabetes. The purpose of this study is to learn more about an investigational system to measure blood glucose. This system does not require blood to be drawn from the body, and it does not require a glucose sensor to be worn under the skin (subcutaneously). This device instead estimates blood glucose levels by shining infrared light on the skin and then using sophisticated statistical analysis on how the light bounces back or gets absorbed (spectral data). The researchers in this study will compare the accuracy of the new device to glucose measurement devices that are already approved by the FDA, including glucose meters and subcutaneous continuous glucose monitoring (CGM) sensors. Information learned from this study will be used in the development of tools for managing diabetes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01831752
The ClinicalTrials.gov registry entry for NCT01831752 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01831752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01831752 about?
NCT01831752 is a clinical study titled "Performance Evaluation of a Non-Invasive Glucose Monitor as Compared to CGM Data Acquired by the iPro2". This study is for adults and adolescents with type 1 diabetes. The purpose of this study is to learn more about an investigational system to measure blood glucose. This system does not require blood to be drawn from the body, and it does not require a glucose sensor to be worn under the skin (subcut...
What is the current status of trial NCT01831752?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2013-02. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01831752?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.